The patient received trifluridine/tipiracil plus bevacizumab as third-line therapy; is currently on month 4 of treatment.​ ...

Combination therapy with nogapendekin alfa inbakicept and BCG achieved a 3-year DSS rate of 96% in BCG-unresponsive NMIBC ...

LINKER-MM4 trial shows linvoseltamab monotherapy achieves a 79% overall response rate in newly diagnosed MM patients, with 92 ...

Alongside quarterback Jayden Daniels, the Commanders won't have left tackle Laremy Tunsil on the field vs. the Eagles.

Some younger patients with B-cell acute lymphoblastic leukemia may be able to avoid total body irradiation conditioning prior ...

Twin brothers Argh and Parv Jain have emerged as standout performers in CLAT 2026, clinching AIR 8 and AIR 2 in one of the ...

FlightScope's Mevo Gen2 ($1,299) and i4 Rangefinder ($399) deliver pro-level data without subscriptions. Perfect golf gifts ...

The complete response or better rate was 81.1% with the combination versus 31.1% in the control arm, while patients treated ...

Quinyon Mitchell putting together incredible season – NBCSP Earlier this week, the NFL released its updated data of Pro Bowl ...

Here's a hint: So far, the point guard is having one of the best seasons in franchise history.

Connecting The Dots works to improve how science and mathematics are taught in schools. It emphasises experiential learning, ...

Epcoritamab addition to R2 significantly improves progression-free survival and overall response rates in relapsed follicular ...